Epalinges, Switzerland · Founded 2021 · Privately Held (backing)
Operator of a global cancer real-world data platform designed to enable molecular testing and AI-driven insights for improved cancer care outside the US. Hedera Dx is based in Epalinges, Switzerland and was founded in 2021. Its last reported valuation was $43 million in Mar 2024. It has raised $36.8 million.
Last reported valuation
$43.0M
Oct 2026
Priced at
—
Total raised
$36.8M
Last round
—
Team — not yet on record
No current team members for Hedera Dx are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hedera Dx with a free account
·The complete investor list: 11 names
·Watch Hedera Dx: the Monday email on marks, rounds and moves
